These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 21288085)

  • 1. Trans-splicing, more than meets the eye: multifaceted therapeutics for spinal muscular atrophy.
    Butchbach ME
    Hum Gene Ther; 2011 Feb; 22(2):121-5. PubMed ID: 21288085
    [No Abstract]   [Full Text] [Related]  

  • 2. Combination of SMN trans-splicing and a neurotrophic factor increases the life span and body mass in a severe model of spinal muscular atrophy.
    Shababi M; Glascock J; Lorson CL
    Hum Gene Ther; 2011 Feb; 22(2):135-44. PubMed ID: 20804424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic therapy for spinal muscular atrophy.
    MacKenzie A
    Nat Biotechnol; 2010 Mar; 28(3):235-7. PubMed ID: 20212484
    [No Abstract]   [Full Text] [Related]  

  • 4. Base editing-mediated splicing correction therapy for spinal muscular atrophy.
    Lin X; Chen H; Lu YQ; Hong S; Hu X; Gao Y; Lai LL; Li JJ; Wang Z; Ying W; Ma L; Wang N; Zuo E; Yang H; Chen WJ
    Cell Res; 2020 Jun; 30(6):548-550. PubMed ID: 32210360
    [No Abstract]   [Full Text] [Related]  

  • 5. Sense in antisense therapy for spinal muscular atrophy.
    MacKenzie A
    N Engl J Med; 2012 Feb; 366(8):761-3. PubMed ID: 22356331
    [No Abstract]   [Full Text] [Related]  

  • 6. Therapeutics that directly increase SMN expression to treat spinal muscular atrophy.
    Shababi M; Mattis VB; Lorson CL
    Drug News Perspect; 2010 Oct; 23(8):475-82. PubMed ID: 21031163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutics development for spinal muscular atrophy.
    Sumner CJ
    NeuroRx; 2006 Apr; 3(2):235-45. PubMed ID: 16554261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and characterization of an SMN2-based intermediate mouse model of Spinal Muscular Atrophy.
    Cobb MS; Rose FF; Rindt H; Glascock JJ; Shababi M; Miller MR; Osman EY; Yen PF; Garcia ML; Martin BR; Wetz MJ; Mazzasette C; Feng Z; Ko CP; Lorson CL
    Hum Mol Genet; 2013 May; 22(9):1843-55. PubMed ID: 23390132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SMN deficiency alters Nrxn2 expression and splicing in zebrafish and mouse models of spinal muscular atrophy.
    See K; Yadav P; Giegerich M; Cheong PS; Graf M; Vyas H; Lee SG; Mathavan S; Fischer U; Sendtner M; Winkler C
    Hum Mol Genet; 2014 Apr; 23(7):1754-70. PubMed ID: 24218366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is RNA manipulation a viable therapy for spinal muscular atrophy?
    Horne C; Young PJ
    J Neurol Sci; 2009 Dec; 287(1-2):27-31. PubMed ID: 19758605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic delivery of scAAV9 expressing SMN prolongs survival in a model of spinal muscular atrophy.
    Valori CF; Ning K; Wyles M; Mead RJ; Grierson AJ; Shaw PJ; Azzouz M
    Sci Transl Med; 2010 Jun; 2(35):35ra42. PubMed ID: 20538619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances and challenges in developing a therapy for spinal muscular atrophy.
    Anderton RS; Mastaglia FL
    Expert Rev Neurother; 2015; 15(8):895-908. PubMed ID: 26200127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antisense oligonucleotides shed new light on the pathogenesis and treatment of spinal muscular atrophy.
    Yee JK; Lin RJ
    Mol Ther; 2012 Jan; 20(1):8-10. PubMed ID: 22215052
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical utility gene card for: Proximal spinal muscular atrophy (SMA) - update 2015.
    Rudnik-Schöneborn S; Eggermann T; Kress W; Lemmink HH; Cobben JM; Zerres K
    Eur J Hum Genet; 2015 Nov; 23(11):. PubMed ID: 25990799
    [No Abstract]   [Full Text] [Related]  

  • 15. [Point mutation analysis of SMN1 gene in patients with spinal muscular atrophy].
    QU YJ; DU J; LI EZ; YANG YL; ZOU LP; BAI JL; WANG H; JIN YW; SONG F
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2011 Apr; 28(2):121-6. PubMed ID: 21462119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rescue of a severe mouse model for spinal muscular atrophy by U7 snRNA-mediated splicing modulation.
    Meyer K; Marquis J; Trüb J; Nlend Nlend R; Verp S; Ruepp MD; Imboden H; Barde I; Trono D; Schümperli D
    Hum Mol Genet; 2009 Feb; 18(3):546-55. PubMed ID: 19010792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Romancing the spliceosome to fight spinal muscular atrophy.
    Swoboda KJ
    N Engl J Med; 2014 Oct; 371(18):1752-4. PubMed ID: 25354110
    [No Abstract]   [Full Text] [Related]  

  • 18. SAHA ameliorates the SMA phenotype in two mouse models for spinal muscular atrophy.
    Riessland M; Ackermann B; Förster A; Jakubik M; Hauke J; Garbes L; Fritzsche I; Mende Y; Blumcke I; Hahnen E; Wirth B
    Hum Mol Genet; 2010 Apr; 19(8):1492-506. PubMed ID: 20097677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antisense rescues babies from killer disease.
    Wadman M
    Science; 2016 Dec; 354(6318):1359-1360. PubMed ID: 27980162
    [No Abstract]   [Full Text] [Related]  

  • 20. Neurodevelopmental consequences of Smn depletion in a mouse model of spinal muscular atrophy.
    Liu H; Shafey D; Moores JN; Kothary R
    J Neurosci Res; 2010 Jan; 88(1):111-22. PubMed ID: 19642194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.